Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

IMVTW - Immunovant Inc Warrant 2019-18.12.24 On Immunovant

Previous close
6.87
0   0%

Share volume: 0
Last Updated: Mon 15 Jun 2020 06:00:00 AM CEST
Financial Conglomerates: 0.01%

PREVIOUS CLOSE
CHG
CHG%
$6.87
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
87%
Profitability 93%
Dept financing 43%
Liquidity 60%
Performance 100%
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$6.87
P/E Ratio 
N/A
DAY RANGE
$6.87 - $6.87
EPS 
$0.00
52 WEEK RANGE
$0.00 - $0.00
52 WEEK CHANGE
$0.00
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
81.812 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$0
AVERAGE 30 VOLUME 
$0
Company detail
CEO: Peter Salzmann
Region: US
Website: http://www.immunovant.com
Employees: 0
IPO year: -
Issue type:
Market: NASDAQ
Industry: Financial Conglomerates
Sector: Finance

Immunovant, Inc. is a clinical-stage biopharmaceutical company. It focuses on enabling normal lives for patients with autoimmune diseases. The company was founded in 2018 and is headquartered in New York, NY.

Recent news